A detailed history of Susquehanna International Group, LLP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 57,239 shares of IONS stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,239
Previous 95,858 40.29%
Holding current value
$2.09 Million
Previous $4.57 Million 49.82%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $1.55 Million - $2 Million
-38,619 Reduced 40.29%
57,239 $2.29 Million
Q2 2024

Aug 15, 2024

SELL
$36.45 - $47.7 $1.57 Million - $2.06 Million
-43,203 Reduced 31.07%
95,858 $4.57 Million
Q1 2024

May 07, 2024

BUY
$42.03 - $53.55 $3.57 Million - $4.55 Million
84,928 Added 156.89%
139,061 $6.03 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $1.5 Million - $1.79 Million
-34,606 Reduced 39.0%
54,133 $2.74 Million
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $3.03 Million - $3.71 Million
-78,777 Reduced 47.03%
88,739 $4.03 Million
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $3.88 Million - $4.84 Million
111,596 Added 199.56%
167,516 $6.87 Million
Q1 2023

May 16, 2023

SELL
$33.58 - $41.2 $65,548 - $80,422
-1,952 Reduced 3.37%
55,920 $2 Million
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $631,114 - $790,933
17,002 Added 41.6%
57,872 $2.19 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $121,203 - $161,405
3,317 Added 8.83%
40,870 $1.81 Million
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $386,005 - $523,439
-12,173 Reduced 24.48%
37,553 $1.39 Million
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $4.62 Million - $5.72 Million
-154,529 Reduced 75.65%
49,726 $1.84 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $770,579 - $1.06 Million
30,089 Added 17.28%
204,255 $6.22 Million
Q3 2021

Nov 15, 2021

SELL
$33.54 - $40.55 $6.92 Million - $8.37 Million
-206,300 Reduced 54.22%
174,166 $5.84 Million
Q2 2021

Aug 11, 2021

BUY
$34.54 - $47.25 $10.1 Million - $13.8 Million
292,195 Added 331.02%
380,466 $15.2 Million
Q1 2021

May 17, 2021

BUY
$42.51 - $63.78 $1.68 Million - $2.52 Million
39,578 Added 81.28%
88,271 $3.97 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $10.4 Million - $13.8 Million
-229,193 Reduced 82.48%
48,693 $2.75 Million
Q3 2020

Nov 16, 2020

SELL
$47.45 - $62.95 $2.11 Million - $2.8 Million
-44,520 Reduced 13.81%
277,886 $13.2 Million
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $2.63 Million - $3.42 Million
-56,087 Reduced 14.82%
322,406 $19 Million
Q1 2020

May 15, 2020

BUY
$41.6 - $63.4 $9.16 Million - $14 Million
220,271 Added 139.22%
378,493 $17.9 Million
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $3.56 Million - $4.32 Million
-66,173 Reduced 29.49%
158,222 $9.56 Million
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $1.97 Million - $2.4 Million
33,279 Added 17.41%
224,395 $13.4 Million
Q2 2019

Aug 16, 2019

BUY
$62.09 - $86.14 $8.82 Million - $12.2 Million
142,086 Added 289.79%
191,116 $12.3 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $2.03 Million - $2.82 Million
32,724 Added 200.69%
49,030 $3.15 Million
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $5.4 Million - $8.28 Million
-101,977 Reduced 86.21%
16,306 $1.32 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $176,212 - $241,911
4,063 Added 3.56%
118,283 $6.39 Million
Q3 2018

Nov 14, 2018

SELL
$42.88 - $53.7 $9.32 Million - $11.7 Million
-217,303 Reduced 65.55%
114,220 $5.89 Million
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $6.18 Million - $7.73 Million
152,447 Added 85.13%
331,523 $13.8 Million
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $228,995 - $285,984
5,195 Added 2.99%
179,076 $7.89 Million
Q4 2017

Feb 14, 2018

BUY
$50.3 - $64.39 $3.22 Million - $4.12 Million
63,971 Added 58.2%
173,881 $8.75 Million
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $5.01 Million - $6.55 Million
109,910
109,910 $5.57 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.